Claudio Dazzi

1.8k total citations
57 papers, 982 citations indexed

About

Claudio Dazzi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Claudio Dazzi has authored 57 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 17 papers in Surgery. Recurrent topics in Claudio Dazzi's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Claudio Dazzi is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Claudio Dazzi collaborates with scholars based in Italy, United Kingdom and China. Claudio Dazzi's co-authors include Anna Cariello, M. Marangolo, Alessandro Gamboni, Rita Chiari, Angelo Delmonte, Lucio Crinò, Maximilian Papi, Marita Mariotti, Elisa Chiadini and Laura Capelli and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Claudio Dazzi

54 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudio Dazzi Italy	17	556	494	220	211	179	57	982
B. Mirtsching United States	12	1.1k 2.1×	459 0.9×	182 0.8×	288 1.4×	136 0.8×	27	1.3k
J.J. Lafitte France	13	504 0.9×	481 1.0×	296 1.3×	190 0.9×	126 0.7×	39	930
Daiki Masuya Japan	16	512 0.9×	358 0.7×	412 1.9×	159 0.8×	85 0.5×	49	1.0k
N. Androulakis Greece	20	1.1k 2.0×	681 1.4×	236 1.1×	290 1.4×	124 0.7×	46	1.3k
Tracy Proverbs‐Singh United States	7	688 1.2×	268 0.5×	210 1.0×	75 0.4×	96 0.5×	14	1.1k
Daniel Rauch Switzerland	20	711 1.3×	385 0.8×	149 0.7×	143 0.7×	89 0.5×	53	1.1k
Florian Würschmidt Germany	19	330 0.6×	500 1.0×	104 0.5×	316 1.5×	51 0.3×	49	1.0k
William H. Isacoff United States	16	499 0.9×	223 0.5×	152 0.7×	146 0.7×	138 0.8×	25	804
Pavlos Papakotoulas Greece	16	777 1.4×	426 0.9×	144 0.7×	292 1.4×	148 0.8×	52	1.0k
Do Hyoung Lim South Korea	15	725 1.3×	642 1.3×	202 0.9×	126 0.6×	75 0.4×	39	1.1k

Countries citing papers authored by Claudio Dazzi

Since Specialization

Citations

This map shows the geographic impact of Claudio Dazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Dazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Dazzi more than expected).

Fields of papers citing papers by Claudio Dazzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Dazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Dazzi. The network helps show where Claudio Dazzi may publish in the future.

Co-authorship network of co-authors of Claudio Dazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Dazzi. A scholar is included among the top collaborators of Claudio Dazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Dazzi. Claudio Dazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gelsomino, Francesco, Marcello Tiseo, Fausto Barbieri, et al.. (2020). Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL). British Journal of Cancer. 123(1). 26–32. 19 indexed citations

Landi, Lorenza, Antonio Chella, Rita Chiari, et al.. (2017). MA07.06 Crizotinib in ROS1 Rearranged or MET Deregulated Non-Small-Cell Lung Cancer (NSCLC): Preliminary Results of the METROS Trial. Journal of Thoracic Oncology. 12(1). S380–S381. 4 indexed citations

Canale, Matteo, Elisabetta Petracci, Angelo Delmonte, et al.. (2016). Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors. Clinical Cancer Research. 23(9). 2195–2202. 196 indexed citations

Franceschi, Enrico, Roberta Depenni, Alexandro Paccapelo, et al.. (2016). Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study. Journal of Neuro-Oncology. 128(1). 157–162. 20 indexed citations

Ulivi, Paola, Elisa Chiadini, Claudio Dazzi, et al.. (2015). Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy. Clinical Lung Cancer. 17(5). 384–390. 75 indexed citations

Lopci, Egesta, Ilaria Grassi, Domenico Rubello, et al.. (2015). Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT. Clinical Nuclear Medicine. 41(2). e87–e92. 31 indexed citations

Tiseo, Marcello, Luca Boni, Francesca Ambrosio, et al.. (2014). Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial. Clinical Lung Cancer. 16(1). 67–70. 17 indexed citations

Erdas, Enrico, et al.. (2012). Incidence and risk factors for trocar site hernia following laparoscopic cholecystectomy: A long-term follow-up study. Hernia. 16(4). 431–437. 43 indexed citations

Passardi, Alessandro, Lorenzo Cecconetto, Monia Dall’Agata, et al.. (2008). Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer. Journal of Translational Medicine. 6(1). 65–65. 4 indexed citations

10.

Giorgi, Ugo De, Bernadette Vertogen, Giuseppe Monti, et al.. (2006). A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization. Bone Marrow Transplantation. 38(6). 407–412. 28 indexed citations

11.

Dazzi, Claudio, Anna Cariello, Petros Giovanis, et al.. (2003). Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Annals of Oncology. 14(4). 559–563. 54 indexed citations

12.

Dazzi, Claudio, Anna Cariello, Serena Magi, et al.. (2003). A High Cytosol Value of Urokinase-Type Plasminogen Activator (uPA) May Be Predictive of Early Relapse in Primary Breast Cancer. Cancer Investigation. 21(2). 208–216. 11 indexed citations

13.

Rosti, Giovanni, Patrizia Ferrante, Jonathan A. Ledermann, et al.. (2002). High-dose chemotherapy for solid tumors: results of the EBMT. Critical Reviews in Oncology/Hematology. 41(2). 129–140. 21 indexed citations

14.

Dazzi, Claudio, Anna Cariello, Giovanni Rosti, et al.. (2000). Relationships between total CD34+ cells reinfused, CD34+ subsets and engraftment kinetics in breast cancer patients.. PubMed. 85(4). 396–402. 7 indexed citations

15.

Dazzi, Claudio, Anna Cariello, Giovanni Rosti, et al.. (2000). Is There Any Difference in PBPC Mobilization Between Cyclophosphamide Plus G-CSF and G-CSF Alone in Patients with Non-Hodgkin's Lymphoma?. Leukemia & lymphoma. 39(3-4). 301–310. 37 indexed citations

16.

Dazzi, Claudio, Anna Cariello, Giovanni Rosti, et al.. (1999). Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases. Bone Marrow Transplantation. 23(6). 529–532. 14 indexed citations

17.

Dazzi, Claudio, Anna Cariello, L Solaini, et al.. (1999). Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer. Lung Cancer. 24(2). 81–88. 36 indexed citations

18.

Fiorentini, G., D Poddie, Maurizio Cantore, et al.. (1994). Hepatic arterial infusion (HAI) of high dose chemotherapy plus caval chemofiltration vs HAI of prolonged low doses in patients with liver matastases from colorectal carcinoma: Result of a prospective randomized trial.. 7. 165–168. 3 indexed citations

19.

Marangolo, M., A. Tienghi, G. Fiorentini, et al.. (1992). Treatment of pelvic osteosarcoma. Annals of Oncology. 3. S19–S21. 13 indexed citations

20.

Tummarello, Diego, Francesco Guidi, U. Torresi, et al.. (1990). Induction Chemo-Radiotherapy and Maintenance Alternating Chemotherapy for Small Cell Lung Cancer. Acta Oncologica. 29(4). 417–420. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact